mMCPcounter analysis of the tumor RNAseq data predicted an increase in CD8 + T cells (Fig. 5A) and monocytes (Figure S7A), and a decrease in B-derived cells and cells of the lymphatics (p < 0.01) in tumors from the SX-682-treated Braf/Pten mice (Figure S7A). Here, CD8A is linked to neoplasm.